Reconstitution Math: Calculating Concentration from a mg-per-Vial Lyophilized Peptide

A lyophilized research peptide arrives as a powder labeled with a gross mass — typically 5 mg, 10 mg, or higher. To use the compound in any research application, the powder must be dissolved in solvent, and the resulting solution must have a known, calculable concentration. This article walks through the concentration math that every researcher should be able to do from memory: converting between mg, mL, μg, and (where applicable) International Units (IU) for a reconstituted research peptide.

This is a methodology article, not a dosing article. The math here is the same math that any analytical chemist or researcher would use to prepare a working solution from a stock vial. It is intended for laboratory and animal-research applications under appropriate institutional oversight. The article does not address human dosing, which is outside the scope of research-use-only compounds.

The two numbers on the vial

Every lyophilized research peptide has two relevant numbers on its label and CoA:

Gross mass — the labeled total mass of solid in the vial. This includes the peptide itself, any counterion salts (trifluoroacetate or acetate, residual from the final purification step), and residual water from the lyophilization process. A vial labeled “10 mg” contains 10 mg of total solid.
Net peptide content — the percentage of the gross mass that is the actual peptide molecule, separated from counterion + residual water. A research-grade CoA reports this as a percent. Typical values are 80–95% of the gross mass. A 10-mg vial with 85% net peptide content contains 8.5 mg of peptide and 1.5 mg of counterion / water.

For the analytical-chemistry definition of net peptide content and how to read it on a CoA, see article on how to read a peptide Certificate of Analysis.

For all concentration calculations in a research workflow, the gross mass is the starting number unless the researcher’s protocol requires correction to net peptide content. Many published animal-research protocols use gross mass as the basis for the prepared concentration; some use net peptide content. The choice is the researcher’s, and the choice should be documented in the protocol.

The basic formula

The fundamental concentration formula is:

Concentration (mg/mL) = mass of peptide (mg) ÷ volume of solvent (mL)

For a 10-mg vial reconstituted in 2 mL of bacteriostatic water:

Concentration = 10 mg ÷ 2 mL = 5 mg/mL = 5000 μg/mL

The output unit is determined by the input units. The mass-of-peptide input is the labeled gross mass for most research workflows (or the net-peptide-content corrected mass, for protocols that specify it).

Worked examples

Example 1: 10-mg vial in 1 mL

A 10-mg vial reconstituted in exactly 1.0 mL of solvent gives:

Concentration = 10 mg ÷ 1 mL = 10 mg/mL = 10,000 μg/mL

This is a high-concentration stock solution, useful when only small working volumes are needed downstream. Each 0.1 mL drawn from this vial contains 1 mg of peptide; each 0.01 mL contains 100 μg.

Example 2: 10-mg vial in 2 mL

The same 10-mg vial reconstituted in 2.0 mL of solvent gives:

Concentration = 10 mg ÷ 2 mL = 5 mg/mL = 5000 μg/mL

Each 0.1 mL drawn from this vial contains 500 μg; each 0.02 mL contains 100 μg.

Example 3: 5-mg vial in 2.5 mL

A 5-mg vial reconstituted in 2.5 mL of solvent gives:

Concentration = 5 mg ÷ 2.5 mL = 2 mg/mL = 2000 μg/mL

This is a common “convenience” concentration that makes 0.5-mL aliquots = 1 mg per aliquot, useful for short-term aliquoting workflows.

Example 4: working-solution dilution from a stock

If a research protocol calls for a working concentration of 0.5 mg/mL and the stock solution is 5 mg/mL, the dilution factor is 10× (i.e., 1 part stock + 9 parts solvent). For 1.0 mL of working solution:

Stock volume = 1.0 mL × (0.5 mg/mL ÷ 5 mg/mL) = 0.1 mL Solvent to add = 1.0 mL − 0.1 mL = 0.9 mL

This is the standard dilution equation C₁V₁ = C₂V₂, rearranged for V₁.

What is “IU” and when does it apply?

International Units (IU) is a regulatory-pharmacology unit that historically applied to certain biological substances (insulin, gonadotropins, growth hormone, some enzymes) where the activity-per-mass varied by source or preparation and a pharmacopoeial standard was used to define the unit. For research peptides that are pure single-molecule preparations of a defined sequence, the IU concept generally does not apply — concentration is reported in mg/mL or μg/mL based on the molecular identity.

A few research compounds (notably human growth hormone, hCG, gonadotropins) have historical IU conversions that are reported in the legacy pharmacopoeial literature. For these, the conversion is compound-specific and must be looked up. For example:

Human growth hormone (hGH) — the World Health Organization Reference Preparation defines approximately 3 IU per 1 mg of pure recombinant hGH.
Synthetic recombinant insulin — the standard is approximately 28 IU per 1 mg.

These are pharmacopoeial conversion factors for specific historical biologics. For the majority of synthetic research peptides (BPC-157, TB-500, GHK-Cu, GLP-1 analogs, GHRH analogs, melanocortin analogs, etc.) IU is not used — concentration is mg/mL or μg/mL. The IU concept is also not applicable to small-molecule research compounds (5-Amino-1MQ, NAD⁺).

If a researcher encounters an “IU” specification in a published animal-research protocol, the conversion factor should be looked up against the specific reference preparation cited in that paper. The IU concept is not a universal mass-to-activity converter.

Reconstitution solvent: bacteriostatic water

For most research peptide applications, the recommended reconstitution solvent is sterile bacteriostatic water — sterile water with 0.9% benzyl alcohol added as a bacteriostatic agent. The benzyl alcohol suppresses microbial growth, which extends the usable shelf life of the reconstituted solution to roughly 2-4 weeks under refrigeration (compared to days for sterile saline or sterile water without bacteriostatic agent).

Sterile saline (0.9% NaCl) is an acceptable alternative for short-term research use, particularly for assays where benzyl alcohol may interfere. Sterile water without a bacteriostatic agent is the shortest-lived option and should be used only when fresh reconstitution before use is the workflow.

Bacteriostatic water and related reconstitution supplies are available from most research-supply vendors.

Reconstitution technique

The math gives the target concentration; the technique determines whether the actual concentration matches the calculation. Standard reconstitution best practices for a research peptide:

Let the vial reach room temperature before opening to prevent condensation from entering the vial when the seal is broken or the rubber septum is pierced.
Use an accurate syringe for the solvent volume. A 1-mL or 3-mL graduated syringe is the standard tool; the volume must be drawn and dispensed precisely.
Inject the solvent along the wall of the vial, not directly onto the lyophilized cake. The slow stream allows the cake to dissolve gently rather than being disrupted by a high-pressure jet.
Swirl gently to dissolve. Do not shake vigorously; mechanical shear can damage the peptide structure. Some peptides take a few minutes to fully dissolve; allow the time without agitation.
Inspect the solution. A properly reconstituted peptide solution is clear and colorless (or, in the case of GHK-Cu, blue). Cloudiness, particulates, or color changes are indicators of contamination or degradation.
Label clearly. Record the compound, the labeled gross mass, the solvent volume, the calculated concentration, the date of reconstitution, and the solvent identity. This is the documentation that ties the working solution to the lot CoA.

For the full reconstitution-and-storage protocol, see article on lyophilized vs. reconstituted peptide storage.

Common reconstitution mistakes (research-context)

The most frequent sources of concentration error in a research workflow:

Solvent volume not measured accurately. An eyeballed 2 mL is often actually 1.7 or 2.3 mL; the resulting concentration is off by 10–15%.
Mass-from-vial assumed without checking the CoA. A vial labeled “10 mg” with a CoA reporting 82% net peptide content actually contains 8.2 mg of peptide. Protocols that require net-peptide accuracy must use the CoA value.
Wrong solvent. Some peptides require specific reconstitution conditions (e.g., low-pH buffer for certain insoluble peptides); using bacteriostatic water on a peptide that requires a different solvent gives a solution that has not fully dissolved.
Freeze-thaw cycling. Repeated freezing and thawing of the reconstituted stock degrades concentration through aggregation losses. The right practice is to aliquot before freezing and thaw each aliquot only once.
No documentation. Without a written record of the reconstitution date and solvent volume, the working solution is not traceable to the lot, and the experiment is not reproducible.

Summary

The fundamental peptide-reconstitution math is concentration = mass ÷ volume. The mass input is the gross-mass label on the vial (or the CoA-reported net peptide content, for protocols that require net-peptide accuracy). The solvent volume is whatever the researcher draws — and it must be drawn accurately. The output units (mg/mL or μg/mL) are determined by the input units. IU is not a universal unit and applies only to a small set of historical biologics; it is not used for the typical research peptide.

Good reconstitution technique — room-temperature vial, accurate solvent volume, gentle dissolution, clear labeling — is what makes the calculated concentration match the actual concentration in the working solution. A research workflow that documents the reconstitution math, the solvent identity, and the date of reconstitution is a workflow that produces reproducible research-grade data.

Selected sources

United States Pharmacopeia. Chapters on protein and peptide reference standards (USP-NF, general guidance). Consult the current edition for specific compendial conversion factors and definitions.
World Health Organization Expert Committee on Biological Standardization. WHO International Reference Preparations and biological standards. Available at https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications.
International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS). Technical guidance on solvent compatibility for peptide solutions.
Steinmetz MP, et al. “Reconstitution and stability of peptide preparations: practical considerations for the research laboratory.” General methodology reference; see published laboratory manuals on peptide chemistry (e.g., Houghten methodology in the SPPS literature).
Liu DT. “Effects of containers and additives on the stability of peptides in solution.” Reference text on peptide stability; methodology applies to research-use preparations.

Research Use Only — Disclaimer

The research peptides discussed on this page are described for laboratory and research purposes only. They are intended exclusively for in vitro experimentation and for use in animal studies under appropriate institutional oversight. They are not drugs, dietary supplements, cosmetics, or food additives. They are not for human consumption, not for veterinary use in companion animals, and not for any therapeutic, diagnostic, preventive, or palliative purpose.

Nothing on this page constitutes medical advice or dosing guidance for humans. The reconstitution math described here is the standard mass-per-volume calculation used to prepare research-grade working solutions for laboratory and animal-research use only.

Buyers must be at least 21 years of age and must agree to use products strictly for research purposes.